Wellcome Wolfson Institute for Experimental Medicine

Medicine & Life Sciences

1. Macular Degeneration 100%
2. Retina 63%
3. Glaucoma 62%
4. Cystic Fibrosis 61%
5. Eye 60%
6. Diabetic Retinopathy 59%
7. Endothelial Cells 45%
8. Adult Respiratory Distress Syndrome 39%
9. Systematic Reviews 39%
10. Randomized Controlled Trials 36%
11. Therapeutics 36%
12. Inflammation 35%
13. Lung 33%
14. Retinal Vessels 32%
15. Vascular Endothelial Growth Factor A 31%
16. Blood Vessels 31%
17. Proteins 28%
18. Critical Illness 26%
19. Genes 26%
20. Biomarkers 25%
21. SARS Virus 25%
22. Epithelial Cells 24%
23. Cough 23%
24. Asthma 22%
25. Infections 22%
26. Smooth Muscle Myocytes 22%
27. Advanced Glycation End Products 22%
28. Intraocular Pressure 21%
29. Macular Edema 21%
30. Placebos 21%
31. Chronic Obstructive Pulmonary Disease 21%
32. Cardiac Myocytes 20%
33. Peptides 20%
34. Open Angle Glaucoma 20%
35. Macrophages 19%
36. Fasciola hepatica 18%
37. Stem Cells 17%
38. In Vitro Techniques 17%
39. Bronchiectasis 17%
40. Population 17%
41. Heart Failure 16%
42. Retinal Pigment Epithelium 16%
43. Ocular Vision 16%
44. Critical Care 15%
45. Mesenchymal Stem Cells 15%
46. Visual Acuity 15%
47. Phenotype 15%
48. Clinical Trials 15%
49. Intensive Care Units 15%
50. Smooth Muscle 15%
51. Confidence Intervals 15%
52. MicroRNAs 15%
53. Messenger RNA 14%
54. Retinal Pigments 14%
55. Lasers 14%
56. Type 1 Diabetes Mellitus 14%
57. Diabetic Nephropathies 14%
58. Mutation 14%
59. Lung Diseases 14%
60. Visual Field Tests 13%
61. Fibrosis 13%
62. Qatar 13%
63. Sputum 13%
64. Cost-Benefit Analysis 13%
65. Cell Differentiation 13%
66. Cohort Studies 13%
67. Oxidative Stress 13%
68. Endothelial Progenitor Cells 13%
69. Type 2 Diabetes Mellitus 13%
70. Mortality 13%
71. Diabetes Complications 13%
72. Cytokines 12%
73. Anti-Bacterial Agents 12%
74. Retinal Degeneration 12%
75. Ranibizumab 12%
76. Receptor for Advanced Glycation End Products 12%
77. Northern Ireland 12%
78. Artificial Respiration 12%
79. Pericytes 12%
80. Pre-Eclampsia 12%
81. Inflammasomes 11%
82. Membranes 11%
83. Proto-Oncogene Proteins c-akt 11%
84. Pharmaceutical Preparations 11%
85. Endothelium 11%
86. Health Care Outcome Assessment 11%
87. Pseudomonas aeruginosa 11%
88. Optic Disk 11%
89. Gene Expression 11%
90. Ophthalmologists 11%
91. Trematoda 11%
92. Up-Regulation 11%
93. Polymerase Chain Reaction 10%
94. cathepsin S 10%
95. Protein Isoforms 10%